Total Payments
$173,823
2024 Payments
$4,017
Companies
62
Transactions
1,981
Medicare Patients
10,637
Medicare Billing
$2.4M
Payment Breakdown by Category
Other$112,053 (64.5%)
Food & Beverage$44,503 (25.6%)
Consulting$8,534 (4.9%)
Travel$7,772 (4.5%)
Education$759.90 (0.4%)
Gifts$200.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $112,053 | 45 | 64.5% |
| Food and Beverage | $44,503 | 1,881 | 25.6% |
| Consulting Fee | $8,534 | 8 | 4.9% |
| Travel and Lodging | $7,772 | 27 | 4.5% |
| Education | $759.90 | 19 | 0.4% |
| Gift | $200.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $50,722 | 69 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $44,704 | 79 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $24,693 | 105 | $0 (2021) |
| Mylan Specialty L.P. | $12,578 | 62 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $6,479 | 116 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $5,718 | 183 | $0 (2024) |
| GlaxoSmithKline, LLC. | $4,841 | 250 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $3,122 | 154 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $2,596 | 83 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $1,603 | 60 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,017 | 172 | HARMONY BIOSCIENCES LLC ($806.90) |
| 2023 | $18,554 | 316 | Mallinckrodt Hospital Products Inc. ($11,436) |
| 2022 | $26,075 | 255 | Mallinckrodt Hospital Products Inc. ($18,458) |
| 2021 | $13,613 | 236 | Mallinckrodt Hospital Products Inc. ($7,379) |
| 2020 | $13,349 | 192 | Mallinckrodt Hospital Products Inc. ($7,256) |
| 2019 | $50,870 | 309 | Mallinckrodt Enterprises LLC ($32,442) |
| 2018 | $17,261 | 249 | Mallinckrodt LLC ($6,676) |
| 2017 | $30,085 | 252 | Mallinckrodt LLC ($11,603) |
All Payment Transactions
1,981 individual payment records from CMS Open Payments — Page 1 of 80
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Immunology and Neurology | ||||||
| 12/10/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Allergy and Immunology | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/20/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $24.31 | General |
| Category: Narcoplepsy | ||||||
| 08/30/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $16.45 | General |
| Category: Narcoplepsy | ||||||
| 08/29/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Narcoplepsy | ||||||
| 08/14/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $3.91 | General |
| Category: HFCWO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,559 | 19,753 | $3.1M | $572,554 |
| 2022 | 28 | 2,752 | 18,503 | $3.6M | $656,525 |
| 2021 | 25 | 2,606 | 16,429 | $3.3M | $615,616 |
| 2020 | 28 | 2,720 | 13,776 | $2.3M | $510,904 |
Total Patients
10,637
Total Services
68,461
Medicare Billing
$2.4M
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 253 | 1,231 | $738,600 | $139,519 | 18.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 89 | 5,820 | $174,600 | $85,382 | 48.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 85 | 276 | $236,910 | $54,841 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 153 | 315 | $220,500 | $50,992 | 23.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 262 | 1,245 | $373,500 | $45,454 | 12.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 55 | 59 | $72,275 | $36,225 | 50.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 66 | 227 | $136,200 | $25,002 | 18.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 41 | 42 | $51,450 | $24,563 | 47.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 46 | 3,312 | $49,680 | $13,521 | 27.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 35 | 190 | $29,450 | $13,376 | 45.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 172 | 871 | $174,400 | $11,450 | 6.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 150 | $75,000 | $9,774 | 13.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 37 | 1,140 | $17,100 | $9,225 | 53.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 54 | $32,400 | $8,664 | 26.7% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 96 | 746 | $149,200 | $8,648 | 5.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 106 | 109 | $21,800 | $5,992 | 27.5% |
| 94680 | Test to measure exhaled air for evaluation of lung function during rest and exercise | Office | 2023 | 110 | 114 | $17,100 | $5,837 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $23,800 | $5,185 | 21.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 107 | 110 | $16,500 | $4,613 | 28.0% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 173 | 322 | $64,400 | $3,776 | 5.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 111 | 119 | $17,850 | $3,652 | 20.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $9,600 | $2,488 | 25.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 33 | 39 | $7,800 | $1,014 | 13.0% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 50 | 55 | $5,500 | $932.25 | 17.0% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 11 | 11 | $16,940 | $862.73 | 5.1% |
About Dr. Gurmit Gill, MD
Dr. Gurmit Gill, MD is a Pulmonary Disease healthcare provider based in Garden City, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730134339.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gurmit Gill, MD has received a total of $173,823 in payments from pharmaceutical and medical device companies, with $4,017 received in 2024. These payments were reported across 1,981 transactions from 62 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($112,053).
As a Medicare-enrolled provider, Gill has provided services to 10,637 Medicare beneficiaries, totaling 68,461 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine, Sleep Medicine
- Location Garden City, NY
- Active Since 05/23/2006
- Last Updated 02/14/2017
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1730134339
Products in Payments
- ACTHAR (Biological) $95,426
- LONHALA MAGNAIR (Drug) $12,787
- Yupelri (Drug) $10,439
- UTIBRON (Drug) $9,504
- SPIRIVA RESPIMAT (Drug) $3,858
- DUPIXENT (Biological) $3,753
- YUPELRI (Drug) $1,952
- NUCALA (Biological) $1,865
- SEEBRI (Drug) $1,829
- TRELEGY ELLIPTA (Drug) $1,798
- SYMBICORT (Drug) $1,705
- WAKIX (Drug) $1,619
- Wakix (Drug) $1,503
- Xolair (Biological) $1,334
- XYWAV (Drug) $1,158
- FASENRA (Biological) $1,139
- Prolastin-C Liquid (Biological) $1,043
- TEZSPIRE (Biological) $870.33
- OFEV (Drug) $841.44
- BREZTRI (Drug) $765.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.